U.S. regulators defend requiring more data on monkeypox drug
By Julie Steenhuysen CHICAGO (Reuters) - As U.S. monkeypox cases rise, U.S. health agencies in a medical journal article published on Wednesday defended
Source: shorenewsnetwork.com
Page 33 - Jay Varma News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Jay Varma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Jay Varma Today - Breaking & Trending Today
U.S. regulators defend requiring more data on monkeypox drug
By Julie Steenhuysen CHICAGO (Reuters) - As U.S. monkeypox cases rise, U.S. health agencies in a medical journal article published on Wednesday defend...
Source: 933thedrive.com
U.S. regulators defend requiring more data on monkeypox drug
By Julie Steenhuysen CHICAGO (Reuters) - As U.S. monkeypox cases rise, U.S. health agencies in a medical journal article published on Wednesday defend...
Source: wtvbam.com
Monkeypox continues its global assault as governments do nothing to bring the pandemic to an end
Global monkeypox cases have risen to over 23,000 spanning almost 90 countries and territories. Despite the recent declaration of a Public Health Emergency of International Concern, little is being done to address the rapidly evolving crisis.
Source: wsws.org
Monkeypox: Access to experimental treatment uneven, doctors say
A drug is available for monkeypox patients who have or who are at risk of severe disease, but doctors say they continue to face challenges getting access to it. The U.S. Food and Drug Administration hasn't approved tecovirimat -- sold under the brand name Tpoxx -- specifically for use against monkeypox, but the U.S. Centers for Disease Control and Prevention has made the drug available.
Source: ctvnews.ca